(a)
|
|
1 Year
|
3 Year
|
5 Year
|
10 Year
|
Since Inception(1)
|
|
Coho Relative Value Equity Fund(2)
|
0.57%
|
7.23%
|
8.86%
|
8.97%
|
8.99%
|
S&P 500® Index(3)
|
20.82%
|
10.99%
|
14.30%
|
12.62%
|
12.72%
|
Russell 1000® Value Index(4)
|
6.08%
|
9.23%
|
9.28%
|
8.80%
|
8.88%
|
(1)
|
Period from Fund inception through January 31, 2024. The Fund commenced operations on August 14, 2013.
|
(2)
|
On November 22, 2019, the Fund’s Institutional Class shares were merged into the Advisor Class shares. The Advisor Class name was subsequently discontinued following the merger.
|
(3)
|
The S&P 500® Index is an unmanaged, capitalization-weighted index generally representative of the U.S.
market for large capitalization stocks. One cannot invest directly in an Index.
|
(4)
|
The Russell 1000® Value Index measures the performance of the small cap value segment of U.S. equity
securities. It includes those Russell 1000® Index companies with lower price-to-book ratios and lower forecasted growth values. One cannot invest directly in
an Index.
|
1 Year
|
3 Year
|
Since Inception(1)
|
|
Coho Relative Value ESG Fund
|
2.04%
|
6.20%
|
7.09%
|
S&P 500® Index(2)
|
20.82%
|
10.99%
|
12.64%
|
Russell 1000® Value Index(3)
|
6.08%
|
9.23%
|
7.60%
|
(1)
|
Period from Fund inception through January 31, 2024. The Fund commenced operations on November 27, 2019.
|
(2)
|
The S&P 500® Index is an unmanaged, capitalization-weighted index generally representative of the U.S.
market for large capitalization stocks. One cannot invest directly in an Index.
|
(3)
|
The Russell 1000® Value Index measures the performance of the small cap value segment of U.S. equity
securities. It includes those Russell 1000® Index companies with lower price-to-book ratios and lower forecasted growth values. One cannot invest directly in
an Index.
|
Beginning
|
Ending
|
Expenses Paid
|
|
Account Value
|
Account Value
|
During Period(1)
|
|
(8/1/2023)
|
(1/31/2024)
|
(8/1/2023 to 1/31/2024)
|
|
Actual(2)
|
$1,000.00
|
$1,014.00
|
$4.00
|
Hypothetical (5% return before expenses)
|
$1,000.00
|
$1,021.17
|
$4.01
|
(1)
|
Expenses are equal to the Fund’s annualized expense ratio for the most recent six-month period of 0.79%, multiplied by the average account value over the period, multiplied by 184/366 to
reflect the one-half year period.
|
(2)
|
Based on the actual return for the six-month period ended January 31, 2024 of 1.40%.
|
Beginning
|
Ending
|
Expenses Paid
|
|
Account Value
|
Account Value
|
During Period(3)
|
|
(8/1/2023)
|
(1/31/2024)
|
(8/1/2023 to 1/31/2024)
|
|
Actual(4)
|
$1,000.00
|
$1,024.80
|
$4.02
|
Hypothetical (5% return before expenses)
|
$1,000.00
|
$1,021.17
|
$4.01
|
(3)
|
Expenses are equal to the Fund’s annualized expense ratio for the most recent six-month period of 0.79%, multiplied by the average account value over the period, multiplied by 184/366 to
reflect the one-half year period.
|
(4)
|
Based on the actual return for the six-month period ended January 31, 2024 of 2.48%.
|
Ross Stores
|
5.6%
|
||
Cencora
|
5.2%
|
||
W.W. Grainger
|
4.6%
|
||
Lowe’s Companies
|
4.6%
|
||
Microchip Technology
|
4.6%
|
||
Sysco
|
4.6%
|
||
UnitedHealth Group
|
4.2%
|
||
Mondelez International
|
4.0%
|
||
Thermo Fisher Scientific
|
3.8%
|
||
Dollar General
|
3.7%
|
(1)
|
Fund holdings and sector allocations are subject to change at any time and are not recommendations to buy or sell any security.
|
Ross Stores
|
5.2%
|
||
Sysco
|
4.8%
|
||
Microchip Technology
|
4.6%
|
||
Lowe’s Companies
|
4.4%
|
||
Cencora
|
4.4%
|
||
W.W. Grainger
|
4.2%
|
||
Mondelez International
|
4.0%
|
||
UnitedHealth Group
|
4.0%
|
||
Johnson & Johnson
|
3.9%
|
||
Global Payments
|
3.9%
|
(1)
|
Fund holdings and sector allocations are subject to change at any time and are not recommendations to buy or sell any security.
|
Shares
|
Value
|
|||||||
COMMON STOCKS — 98.4%
|
||||||||
Communication Services — 3.2%
|
||||||||
Walt Disney
|
187,470
|
$
|
18,006,494
|
|||||
Consumer Discretionary — 15.9%
|
||||||||
Lowe’s Companies
|
124,018
|
26,395,991
|
||||||
NIKE, Inc. – Class B
|
186,793
|
18,965,093
|
||||||
Ross Stores
|
227,793
|
31,954,802
|
||||||
Service Corp International
|
206,927
|
13,888,940
|
||||||
91,204,826
|
||||||||
Consumer Staples — 20.1%
|
||||||||
Coca-Cola
|
291,774
|
17,357,635
|
||||||
Conagra Brands
|
434,287
|
12,659,466
|
||||||
Dollar General
|
158,529
|
20,936,925
|
||||||
Mondelez International, Inc. – Class A
|
303,494
|
22,843,993
|
||||||
Philip Morris International
|
158,827
|
14,429,433
|
||||||
Sysco
|
324,455
|
26,258,143
|
||||||
114,485,595
|
||||||||
Energy — 3.0%
|
||||||||
Chevron
|
115,170
|
16,979,513
|
||||||
Financials — 12.7%
|
||||||||
Global Payments
|
141,660
|
18,873,362
|
||||||
Marsh & McLennan Companies
|
97,841
|
18,965,500
|
||||||
State Street
|
233,430
|
17,243,474
|
||||||
US Bancorp
|
421,957
|
17,528,094
|
||||||
72,610,430
|
||||||||
Health Care — 31.4%(a)
|
||||||||
Abbott Laboratories
|
108,206
|
12,243,509
|
||||||
Amgen
|
65,051
|
20,442,927
|
||||||
Cencora
|
127,487
|
29,663,675
|
||||||
CVS Health
|
266,680
|
19,832,992
|
||||||
Johnson & Johnson
|
127,717
|
20,294,231
|
||||||
Medtronic PLC
|
220,504
|
19,302,920
|
||||||
Perrigo PLC
|
339,292
|
10,884,488
|
||||||
Thermo Fisher Scientific
|
40,540
|
21,850,249
|
||||||
UnitedHealth Group
|
46,434
|
23,762,135
|
||||||
178,277,126
|
Shares
|
Value
|
|||||||
Industrials — 7.5%
|
||||||||
United Parcel Service, Inc. – Class B
|
114,886
|
$
|
16,302,324
|
|||||
W.W. Grainger
|
29,524
|
26,442,875
|
||||||
42,745,199
|
||||||||
Information Technology — 4.6%
|
||||||||
Microchip Technology
|
309,510
|
26,364,062
|
||||||
Total Common Stocks
|
||||||||
(Cost $494,569,351)
|
560,673,245
|
|||||||
Total Investments — 98.4%
|
||||||||
(Cost $494,569,351)
|
560,673,245
|
|||||||
Money Market Deposit Account — 3.6%(b)
|
20,489,354
|
|||||||
Liabilities in Excess of Other Assets — (2.0)%
|
(11,399,474
|
)
|
||||||
Total Net Assets — 100.0%
|
$
|
569,763,125
|
PLC |
Public Limited Company | |
(a)
|
To the extent that the Fund invests more heavily in a particular industry or sector of the economy, its performance will be especially sensitive to developments that significantly
affect those industries or sectors. See Note 8 in Notes to the Financial Statements.
|
|
(b)
|
The U.S. Bank Money Market Deposit Account (the “MMDA”) is a short-term vehicle in which the Fund holds cash balances. The MMDA will bear interest at a variable rate that is
determined based on market conditions and is subject to change daily. The rate as of January 31, 2024 was 3.27%.
|
Shares
|
Value
|
|||||||
COMMON STOCKS — 95.4%
|
||||||||
Communication Services — 3.0%
|
||||||||
Walt Disney
|
16,591
|
$
|
1,593,566
|
|||||
Consumer Discretionary — 15.2%
|
||||||||
Lowe’s Companies
|
10,900
|
2,319,956
|
||||||
NIKE, Inc. – Class B
|
16,530
|
1,678,291
|
||||||
Ross Stores
|
19,563
|
2,744,297
|
||||||
Service Corp International
|
18,423
|
1,236,552
|
||||||
7,979,096
|
||||||||
Consumer Staples — 21.3%
|
||||||||
Coca-Cola
|
26,840
|
1,596,712
|
||||||
Colgate-Palmolive Co.
|
19,939
|
1,678,864
|
||||||
Conagra Brands
|
42,930
|
1,251,410
|
||||||
Dollar General
|
15,027
|
1,984,616
|
||||||
Mondelez International, Inc. – Class A
|
28,161
|
2,119,678
|
||||||
Sysco
|
31,209
|
2,525,744
|
||||||
11,157,024
|
||||||||
Financials — 14.3%
|
||||||||
Global Payments
|
15,270
|
2,034,422
|
||||||
Marsh & McLennan Companies
|
9,489
|
1,839,348
|
||||||
State Street
|
22,805
|
1,684,605
|
||||||
US Bancorp
|
46,782
|
1,943,324
|
||||||
7,501,699
|
||||||||
Health Care — 32.8%(a)
|
||||||||
Abbott Laboratories
|
15,847
|
1,793,088
|
||||||
Amgen
|
6,211
|
1,951,869
|
||||||
Cencora
|
9,920
|
2,308,186
|
||||||
CVS Health
|
24,440
|
1,817,603
|
||||||
Johnson & Johnson
|
12,825
|
2,037,893
|
||||||
Medtronic PLC
|
22,541
|
1,973,239
|
||||||
Perrigo PLC
|
35,822
|
1,149,170
|
||||||
Thermo Fisher Scientific,
|
3,680
|
1,983,446
|
||||||
UnitedHealth Group
|
4,137
|
2,117,068
|
||||||
17,131,562
|
Shares
|
Value
|
|||||||
Industrials — 4.2%
|
||||||||
W.W. Grainger
|
2,474
|
$
|
2,215,813
|
|||||
Information Technology — 4.6%
|
||||||||
Microchip Technology
|
28,110
|
2,394,410
|
||||||
TOTAL COMMON STOCKS
|
||||||||
(Cost $48,746,285)
|
49,973,170
|
|||||||
Total Investments — 95.4%
|
||||||||
(Cost $48,746,285)
|
49,973,170
|
|||||||
Money Market Deposit Account — 4.6%(b)
|
2,431,091
|
|||||||
Other Assets in Excess of Liabilities — 0.0%(c)
|
23,991
|
|||||||
TOTAL NET ASSETS — 100.0%
|
$
|
52,428,252
|
PLC |
Public Limited Company | |
(a)
|
To the extent that the Fund invests more heavily in a particular industry or sector of the economy, its performance will be especially sensitive to developments that significantly affect
those industries or sectors. See Note 8 in Notes to the Financial Statements.
|
|
(b)
|
The U.S. Bank Money Market Deposit Account (the “MMDA”) is a short-term vehicle in which the Fund holds cash balances. The MMDA will bear interest at a variable rate that is determined based
on market conditions and is subject to change daily. The rate as of January 31, 2024 was 3.27%.
|
|
(c)
|
Represents less than 0.05% of net assets.
|
Coho
|
Coho
|
|||||||
Relative Value
|
Relative Value
|
|||||||
Equity Fund
|
ESG Fund
|
|||||||
ASSETS:
|
||||||||
Investments, at value
|
||||||||
(Cost: $494,569,351 & $48,746,285 respectively)
|
$
|
560,673,245
|
$
|
49,973,170
|
||||
Cash Equivalent
|
20,489,354
|
2,431,091
|
||||||
Dividends and interest receivable
|
653,500
|
74,903
|
||||||
Receivable for capital shares sold
|
137,714
|
768
|
||||||
Prepaid expenses
|
12,052
|
14,668
|
||||||
Total assets
|
581,965,865
|
52,494,600
|
||||||
LIABILITIES:
|
||||||||
Payable to investment adviser
|
336,034
|
19,671
|
||||||
Payable for capital shares redeemed
|
11,744,847
|
20,000
|
||||||
Payable for fund administration & accounting fees
|
64,022
|
7,854
|
||||||
Payable for audit fees
|
9,933
|
9,934
|
||||||
Payable for custody fees
|
15,325
|
2,051
|
||||||
Payable for transfer agent fees & expenses
|
9,663
|
3,676
|
||||||
Payable for legal fees
|
3,468
|
—
|
||||||
Payable for compliance fees
|
2,091
|
2,091
|
||||||
Accrued expenses
|
17,357
|
1,071
|
||||||
Total liabilities
|
12,202,740
|
66,348
|
||||||
NET ASSETS
|
$
|
569,763,125
|
$
|
52,428,252
|
||||
NET ASSETS CONSIST OF:
|
||||||||
Paid-in capital
|
$
|
491,195,564
|
$
|
51,592,281
|
||||
Total distributable earnings
|
78,567,561
|
835,971
|
||||||
Net Assets
|
$
|
569,763,125
|
$
|
52,428,252
|
||||
Net Assets
|
$
|
569,763,125
|
$
|
52,428,252
|
||||
Shares issued and outstanding(1)
|
39,674,112
|
4,414,656
|
||||||
Net asset value, redemption price and offering price per share
|
$
|
14.36
|
$
|
11.88
|
(1)
|
Unlimited shares authorized without par value.
|
Coho
|
Coho
|
|||||||
Relative Value
|
Relative Value
|
|||||||
Equity Fund
|
ESG Fund
|
|||||||
INVESTMENT INCOME:
|
||||||||
Dividend income
|
$
|
8,120,939
|
$
|
553,689
|
||||
Interest income
|
312,501
|
32,686
|
||||||
Total investment income
|
8,433,440
|
586,375
|
||||||
EXPENSES:
|
||||||||
Investment adviser fees (See Note 4)
|
2,419,308
|
178,684
|
||||||
Fund administration & accounting fees (See Note 4)
|
206,352
|
23,395
|
||||||
Custody fees (See Note 4)
|
40,877
|
4,689
|
||||||
Transfer agent fees & expenses (See Note 4)
|
31,061
|
10,473
|
||||||
Federal & state registration fees
|
19,270
|
12,181
|
||||||
Trustee fees
|
11,141
|
10,745
|
||||||
Audit fees
|
9,936
|
9,936
|
||||||
Postage & printing fees
|
7,625
|
465
|
||||||
Legal fees
|
7,359
|
7,122
|
||||||
Compliance fees (See Note 4)
|
6,256
|
6,256
|
||||||
Other expenses
|
4,235
|
2,293
|
||||||
Insurance fees
|
3,498
|
1,288
|
||||||
Total expenses before interest expense, waiver
|
2,766,918
|
267,527
|
||||||
Interest expense (See Note 10)
|
4,778
|
460
|
||||||
Total expenses before waiver
|
2,771,696
|
267,987
|
||||||
Less: waiver from investment adviser (See Note 4)
|
(36,246
|
)
|
(65,870
|
)
|
||||
Net expenses
|
2,735,450
|
202,117
|
||||||
NET INVESTMENT INCOME
|
5,697,990
|
384,258
|
||||||
REALIZED AND UNREALIZED
|
||||||||
GAIN (LOSS) ON INVESTMENTS
|
||||||||
Net realized gain (loss) on investments
|
32,499,627
|
(610,677
|
)
|
|||||
Net change in unrealized appreciation/depreciation on investments
|
(43,289,599
|
)
|
1,206,538
|
|||||
Net realized and unrealized gain (loss) on investments
|
(10,789,972
|
)
|
595,861
|
|||||
NET INCREASE (DECREASE) IN NET ASSETS
|
||||||||
RESULTING FROM OPERATIONS
|
$
|
(5,091,982
|
)
|
$
|
980,119
|
Period Ended
|
||||||||
January 31, 2024
|
Year Ended
|
|||||||
(Unaudited)
|
July 31, 2023
|
|||||||
OPERATIONS:
|
||||||||
Net investment income
|
$
|
5,697,990
|
$
|
13,412,739
|
||||
Net realized gain on investments
|
32,499,627
|
50,431,401
|
||||||
Net change in unrealized appreciation/depreciation on investments
|
(43,289,599
|
)
|
(37,452,263
|
)
|
||||
Net increase (decrease) in net assets resulting from operations
|
(5,091,982
|
)
|
26,391,877
|
|||||
CAPITAL SHARE TRANSACTIONS:
|
||||||||
Proceeds from shares sold
|
50,242,748
|
128,543,343
|
||||||
Proceeds from reinvestment of distributions
|
48,733,921
|
38,537,063
|
||||||
Payments for shares redeemed
|
(297,826,678
|
)
|
(244,186,150
|
)
|
||||
Net decrease in net assets resulting from capital share transactions
|
(198,850,009
|
)
|
(77,105,744
|
)
|
||||
DISTRIBUTIONS TO SHAREHOLDERS
|
(67,479,860
|
)
|
(66,256,266
|
)
|
||||
TOTAL DECREASE IN NET ASSETS
|
(271,421,851
|
)
|
(116,970,133
|
)
|
||||
NET ASSETS:
|
||||||||
Beginning of period
|
841,184,976
|
958,155,109
|
||||||
End of period
|
$
|
569,763,125
|
$
|
841,184,976
|
Period Ended
|
||||||||
January 31, 2024
|
Year Ended
|
|||||||
(Unaudited)
|
July 31, 2023
|
|||||||
OPERATIONS:
|
||||||||
Net investment income
|
$
|
384,258
|
$
|
740,405
|
||||
Net realized gain (loss) on investments
|
(610,677
|
)
|
192,268
|
|||||
Net change in unrealized appreciation/depreciation on investments
|
1,206,538
|
446,922
|
||||||
Net increase in net assets resulting from operations
|
980,119
|
1,379,595
|
||||||
CAPITAL SHARE TRANSACTIONS:
|
||||||||
Proceeds from shares sold
|
2,842,807
|
11,182,718
|
||||||
Proceeds from reinvestment of distributions
|
1,027,077
|
1,045,304
|
||||||
Payments for shares redeemed
|
(7,261,926
|
)
|
(4,921,949
|
)
|
||||
Net increase (decrease) in net assets resulting
|
||||||||
from capital share transactions
|
(3,392,042
|
)
|
7,306,073
|
|||||
DISTRIBUTIONS TO SHAREHOLDERS:
|
(1,027,100
|
)
|
(1,066,037
|
)
|
||||
TOTAL INCREASE (DECREASE) IN NET ASSETS
|
(3,439,023
|
)
|
7,619,631
|
|||||
NET ASSETS:
|
||||||||
Beginning of period
|
55,867,275
|
48,247,644
|
||||||
End of period
|
$
|
52,428,252
|
$
|
55,867,275
|
Six Months Ended
|
Year Ended
|
Year Ended
|
Year Ended
|
Year Ended
|
Year Ended
|
|||||||||||||||||||
January 31, 2024
|
July 31,
|
July 31,
|
July 31,
|
July 31,
|
July 31,
|
|||||||||||||||||||
(Unaudited)
|
2023
|
2022
|
2021
|
2020
|
2019
|
|||||||||||||||||||
PER SHARE DATA(1):
|
||||||||||||||||||||||||
Net asset value, beginning of period
|
$
|
15.83
|
$
|
16.48
|
$
|
17.51
|
$
|
14.42
|
$
|
14.20
|
$
|
14.87
|
||||||||||||
INVESTMENT OPERATIONS:
|
||||||||||||||||||||||||
Net investment income
|
0.12
|
(2)
|
0.23
|
(2)
|
0.23
|
(2)
|
0.25
|
(2)
|
0.25
|
(2)
|
0.28
|
|||||||||||||
Net realized and unrealized
|
||||||||||||||||||||||||
gain on investments
|
0.02
|
0.25
|
0.12
|
3.46
|
0.93
|
0.06
|
||||||||||||||||||
Total from investment operations
|
0.14
|
0.48
|
0.35
|
3.71
|
1.18
|
0.34
|
||||||||||||||||||
LESS DISTRIBUTIONS FROM:
|
||||||||||||||||||||||||
Net investment income
|
(0.29
|
)
|
(0.21
|
)
|
(0.24
|
)
|
(0.22
|
)
|
(0.26
|
)
|
(0.23
|
)
|
||||||||||||
Net realized gains
|
(1.32
|
)
|
(0.92
|
)
|
(1.14
|
)
|
(0.40
|
)
|
(0.70
|
)
|
(0.78
|
)
|
||||||||||||
Total distributions
|
(1.61
|
)
|
(1.13
|
)
|
(1.38
|
)
|
(0.62
|
)
|
(0.96
|
)
|
(1.01
|
)
|
||||||||||||
Paid-in capital from redemption fees
|
—
|
—
|
—
|
—
|
(3)
|
—
|
(3)
|
—
|
(3)
|
|||||||||||||||
Net asset value, end of period
|
$
|
14.36
|
$
|
15.83
|
$
|
16.48
|
$
|
17.51
|
$
|
14.42
|
$
|
14.20
|
||||||||||||
TOTAL RETURN(5)
|
1.40
|
%
|
3.12
|
%
|
1.96
|
%
|
26.33
|
%
|
8.45
|
%
|
2.55
|
%
|
||||||||||||
SUPPLEMENTAL DATA AND RATIOS:
|
||||||||||||||||||||||||
Net assets, end
|
||||||||||||||||||||||||
of period (in 000’s)
|
$
|
569,763
|
$
|
841,185
|
$
|
958,155
|
$
|
989,261
|
$
|
741,826
|
$
|
171,070
|
||||||||||||
Ratio of expenses to average net assets:
|
||||||||||||||||||||||||
Before expense waiver/recoupment(6)
|
0.80
|
%
|
0.79
|
%
|
0.78
|
%
|
0.78
|
%
|
0.82
|
%
|
0.93
|
%
|
||||||||||||
After expense waiver/recoupment(6)
|
0.79
|
%
|
0.79
|
%
|
0.79
|
%
|
0.79
|
%
|
0.81
|
%(4)
|
0.94
|
%
|
||||||||||||
Ratio of net investment income
|
||||||||||||||||||||||||
to average net assets:
|
||||||||||||||||||||||||
After expense waiver/recoupment(6)
|
1.65
|
%
|
1.50
|
%
|
1.35
|
%
|
1.53
|
%
|
1.76
|
%
|
1.71
|
%
|
||||||||||||
Portfolio turnover rate(5)
|
9
|
%
|
12
|
%
|
23
|
%
|
26
|
%
|
27
|
%
|
20
|
%
|
(1)
|
On November 22, 2019 the Fund’s Institutional Class shares were merged into the Advisor Class shares. The Advisor Class name was subsequently discontinued following the merger.
|
(2)
|
Per share amounts calculated using the average shares method.
|
(3)
|
Amount per share is less than $0.01.
|
(4)
|
Prior to November 22, 2019, the annual expense limitation was 0.94% of the average daily net assets for the Advisor Class. Thereafter it was 0.79% for the existing class.
|
(5)
|
Not annualized for periods less than one year.
|
(6)
|
Annualized for periods less than one year.
|
Six Months Ended
|
Year Ended
|
Year Ended
|
Year Ended
|
Since Inception(1)
|
||||||||||||||||
January 31, 2024
|
July 31,
|
July 31,
|
July 31,
|
through
|
||||||||||||||||
(Unaudited)
|
2023
|
2022
|
2021
|
July 31, 2020
|
||||||||||||||||
PER SHARE DATA:
|
||||||||||||||||||||
Net asset value, beginning of period
|
$
|
11.83
|
$
|
11.79
|
$
|
12.43
|
$
|
10.19
|
$
|
10.00
|
||||||||||
INVESTMENT OPERATIONS:
|
||||||||||||||||||||
Net investment income
|
0.10
|
0.15
|
0.09
|
0.08
|
0.05
|
|||||||||||||||
Net realized and unrealized
|
||||||||||||||||||||
gain (loss) on investments
|
0.19
|
0.14
|
(0.08
|
)(4)
|
2.37
|
0.15
|
||||||||||||||
Total from investment operations
|
0.29
|
0.29
|
0.01
|
2.45
|
0.20
|
|||||||||||||||
LESS DISTRIBUTIONS FROM:
|
||||||||||||||||||||
Net investment income
|
(0.17
|
)
|
(0.06
|
)
|
(0.08
|
)
|
(0.05
|
)
|
(0.01
|
)
|
||||||||||
Net realized gains
|
(0.07
|
)
|
(0.19
|
)
|
(0.57
|
)
|
(0.16
|
)
|
—
|
|||||||||||
Total distributions
|
(0.24
|
)
|
(0.25
|
)
|
(0.65
|
)
|
(0.21
|
)
|
(0.01
|
)
|
||||||||||
Net asset value, end of period
|
$
|
11.88
|
$
|
11.83
|
$
|
11.79
|
$
|
12.43
|
$
|
10.19
|
||||||||||
TOTAL RETURN(2)
|
2.48
|
%
|
2.52
|
%
|
-0.02
|
%
|
24.26
|
%
|
2.00
|
%
|
||||||||||
SUPPLEMENTAL DATA AND RATIOS:
|
||||||||||||||||||||
Net assets, end of period (in 000’s)
|
$
|
52,428
|
$
|
55,867
|
$
|
48,248
|
$
|
22,203
|
$
|
3,707
|
||||||||||
Ratio of expenses to average net assets:
|
||||||||||||||||||||
Before expense waiver/reimbursement(3)
|
1.05
|
%
|
1.03
|
%
|
1.14
|
%
|
1.81
|
%
|
9.78
|
%
|
||||||||||
After expense waiver/reimbursement(3)
|
0.79
|
%
|
0.79
|
%
|
0.79
|
%
|
0.79
|
%
|
0.79
|
%
|
||||||||||
Ratio of net investment income
|
||||||||||||||||||||
to average net assets:
|
||||||||||||||||||||
After expense waiver/reimbursement(3)
|
1.51
|
%
|
1.44
|
%
|
1.20
|
%
|
1.15
|
%
|
1.48
|
%
|
||||||||||
Portfolio turnover rate(2)
|
7
|
%
|
20
|
%
|
22
|
%
|
25
|
%
|
10
|
%
|
(1)
|
Inception date for the Fund was November 27, 2019.
|
(2)
|
Not annualized for periods less than one year.
|
(3)
|
Annualized for periods less than one year.
|
(4)
|
Net realized and unrealized loss per share in this caption is a balancing amount necessary to reconcile changes in net asset value per share for the year, and may not reconcile with the
aggregate gain on the Statement of Operations due to share transactions for the year.
|
Level 1 —
|
Unadjusted quoted prices in active markets for identical assets or liabilities that the Funds has the ability to access.
|
Level 2 —
|
Observable inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. These inputs may include quoted prices for the
identical instrument on an inactive market, prices for similar instruments, interest rates, prepayment speeds, credit risk, yield curves, default rates and similar data.
|
Level 3 —
|
Unobservable inputs for the asset or liability, to the extent relevant observable inputs are not available, representing the Funds’ own assumptions about the assumptions a market participant
would use in valuing the asset or liability, and would be based on the best information available.
|
Equity Fund
|
||||||||||||||||
Level 1
|
Level 2
|
Level 3
|
Total
|
|||||||||||||
Common Stocks
|
$
|
560,673,245
|
$
|
—
|
$
|
—
|
$
|
560,673,245
|
||||||||
Total Investments in Securities*
|
$
|
560,673,245
|
$
|
—
|
$
|
—
|
$
|
560,673,245
|
||||||||
ESG Fund
|
||||||||||||||||
Level 1
|
Level 2
|
Level 3
|
Total
|
|||||||||||||
Common Stocks
|
$
|
49,973,170
|
$
|
—
|
$
|
—
|
$
|
49,973,170
|
||||||||
Total Investments in Securities*
|
$
|
49,973,170
|
$
|
—
|
$
|
—
|
$
|
49,973,170
|
*
|
Refer to the Schedule of Investments for further information on the classification of investments.
|
Equity Fund
|
ESG Fund
|
|||||||
Expiration
|
Amount
|
Amount
|
||||||
February 2024 – July 2024
|
$
|
—
|
$
|
73,967
|
||||
August 2024 – July 2025
|
—
|
123,655
|
||||||
August 2025 – July 2026
|
18,086
|
122,789
|
||||||
August 2026 – July 2027
|
36,246
|
65,870
|
Equity Fund
|
||||||||
Period Ended
|
Year Ended
|
|||||||
January 31, 2024
|
July 31, 2023
|
|||||||
Shares sold
|
3,479,791
|
8,207,467
|
||||||
Shares issued to holders in reinvestment of distributions
|
3,494,249
|
2,475,260
|
||||||
Shares redeemed
|
(20,449,395
|
)
|
(15,665,309
|
)
|
||||
Net decrease in shares outstanding
|
(13,475,355
|
)
|
(4,982,582
|
)
|
||||
ESG Fund
|
||||||||
Period Ended
|
Year Ended
|
|||||||
January 31, 2024
|
July 31, 2023
|
|||||||
Shares sold
|
250,615
|
965,078
|
||||||
Shares issued to holders in reinvestment of distributions
|
89,596
|
90,704
|
||||||
Shares redeemed
|
(649,747
|
)
|
(424,751
|
)
|
||||
Net increase (decrease) in shares outstanding
|
(309,536
|
)
|
631,031
|
Equity Fund
|
ESG Fund
|
|||||||||||||||
Purchases
|
Sales
|
Purchases
|
Sales
|
|||||||||||||
U.S. Government Securities
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
—
|
||||||||
Other Securities
|
$
|
62,473,121
|
$
|
305,393,614
|
$
|
3,429,907
|
$
|
8,164,436
|
Aggregate
|
Aggregate
|
Net
|
Federal
|
|||||||||||||||
Gross
|
Gross
|
Unrealized
|
Income
|
|||||||||||||||
Appreciation
|
Depreciation
|
Appreciation/ Depreciation
|
Tax Cost
|
|||||||||||||||
Equity Fund
|
$
|
151,793,846
|
$
|
(49,324,475
|
)
|
$
|
102,469,371
|
$
|
738,384,232
|
|||||||||
ESG Fund
|
3,847,649
|
(3,991,757
|
)
|
(144,108
|
)
|
55,955,982
|
Undistributed
|
Undistributed
|
Net
|
Total
|
|||||||||||||||
Ordinary
|
Long-Term
|
Unrealized
|
Distributable
|
|||||||||||||||
Income
|
Capital Gains
|
Appreciation/Depreciation
|
Earnings
|
|||||||||||||||
Equity Fund
|
$
|
7,057,634
|
$
|
41,612,398
|
$
|
102,469,371
|
$
|
151,139,403
|
||||||||||
ESG Fund
|
740,404
|
286,656
|
(144,108
|
)
|
882,952
|
Ordinary
|
Long Term
|
||||||||||||
Income*
|
Capital Gains
|
Total
|
|||||||||||
Equity Fund
|
$
|
12,266,026
|
$
|
55,213,834
|
$
|
67,479,860
|
|||||||
ESG Fund
|
740,404
|
610,676
|
1,027,100
|
Ordinary
|
Long Term
|
||||||||||||
Income*
|
Capital Gains
|
Total
|
|||||||||||
Equity Fund
|
$
|
13,154,185
|
$
|
53,102,081
|
$
|
66,256,266
|
|||||||
ESG Fund
|
271,850
|
794,187
|
1,066,037
|
*
|
For federal income tax purposes, distributions of short-term capital gains are treated as ordinary income distributions.
|
Average
|
Amount Outstanding
|
Interest
|
Maximum
|
Date of
|
||||||||||||||
Fund
|
LOC Agent
|
Borrowings
|
as of January 31, 2024
|
Expense
|
Borrowing
|
Maximum Borrowing
|
||||||||||||
Equity Fund
|
U.S. Bank N.A.
|
$
|
109,989
|
$
|
—
|
$
|
4,778
|
$
|
6,746,000
|
December 1, 2023 –
|
||||||||
December 3, 2023
|
||||||||||||||||||
ESG Fund
|
U.S Bank N.A.
|
10,598
|
—
|
460
|
1,950,000
|
September 18, 2023
|
(b)
|
Not applicable.
|
(a)
|
The Registrant’s President and Treasurer have reviewed the Registrant's disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940 (the “Act”)) as of a date
within 90 days of the filing of this report, as required by Rule 30a-3(b) under the Act and Rules 13a-15(b) or 15d‑15(b) under the Securities Exchange Act of 1934. Based on their review, such officers have concluded that the
disclosure controls and procedures are effective in ensuring that information required to be disclosed in this report is appropriately recorded, processed, summarized and reported and made known to them by others within the Registrant
and by the Registrant’s service provider.
|
(b)
|
There were no significant changes in the Registrant's internal control over financial reporting (as defined in Rule 30a-3(d) under the Act) that occurred during the period covered by this report that
has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting.
|
(a)
|
(1) Any code of ethics or amendment thereto, that is the subject of the disclosure required by Item 2, to the extent that the Registrant intends to satisfy Item 2
requirements through filing an exhibit. 1) Not applicable for semi-annual reports.
|